Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
Rhea-AI Summary
Artivion (NYSE:AORT), a cardiac and vascular surgery company specializing in aortic disease, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will engage in a fireside chat on September 10, 2025, at 2:35 pm ET at the Sheraton New York Times Square Hotel.
Investors can access the live webcast through Artivion's website at www.artivion.com in the Investors section. The webcast recording will remain available for 90 days following the presentation.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, AORT declined 0.11%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.
About Artivion, Inc.
Headquartered in suburban
Contacts:
Artivion | Gilmartin Group LLC | |
Lance A. Berry | Brian Johnston / Laine Morgan | |
Executive Vice President, | Phone: 332-895-3222 | |
Chief Operating Officer & | ||
Chief Financial Officer | ||
Phone: 770-419-3355 | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-conference-302547997.html
SOURCE Artivion, Inc.